Anti-CD33 antibody liposomes represent a cutting-edge approach in the realm of targeted cancer therapy, specifically aimed at acute myeloid leukemia (AML). By leveraging the unique properties of liposomes, these formulations enable the precise delivery of therapeutic agents directly to CD33-expressing tumor cells, thereby maximizing their therapeutic impact while minimizing collateral damage to healthy tissues. This innovative strategy not only enhances treatment efficacy but also aims to improve patient outcomes by reducing the systemic side effects commonly associated with traditional chemotherapy regimens.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-321-sdAb | Recombinant Anti-human CD33 VHH Single Domain Antibody | WB, IP, ChiP, Neut, ELISA | Llama VHH |
There are currently no Customer reviews or questions for VS-1024-FY154. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.